Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE

International Immunology

Volumn 18, Issue 8, 2006, Pages 1211-1219

  Yu, Philipp ^a,f   Wellmann, Ute ^b   Kunder, Sandra ^c   Quintanilla Martinez, Leticia ^c   Jennen, Luise ^c   Dear, Neil ^d   Amann, Kerstin ^e   Bauer, Stefan ^a,f   Winkler, Thomas H ^b   Wagner, Hermann ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Autoimmunity; B cells; Innate immunity; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; CPG OLIGODEOXYNUCLEOTIDE; DNA ANTIBODY; MUTANT PROTEIN; NUCLEOLAR ANTIBODY; PHOSPHOLIPASE; PHOSPHOLIPASE CG2; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DISEASE EXACERBATION; GENE ACTIVATION; GLOMERULONEPHRITIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; RODENT; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DNA; FEMALE; GLOMERULONEPHRITIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PHOSPHOLIPASE C GAMMA; SPLENOMEGALY; TOLL-LIKE RECEPTOR 9;

EID: 33748465308     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl067     Document Type: Article

References (38)

1. Lipsky, P. E. 2001. Systemic lupus erythematosus: An autoimmune disease of B cell hyperactivity. Nat. Immunol. 2:764.
2. Mok, C. C. and Lau, C. S. 2003. Pathogenesis of systemic lupus erythematosus. J. Clin. Pathol. 56:481.
3. Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J. and Marshak-Rothstein, A. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603.
4. Wellmann, U., Letz, M., Herrmann, M., Angermuller, S., Kalden, J. R. and Winkler, T. H. 2005. The evolution of human anti-double-stranded DNAautoantibodies. Proc. Natl Acad. Sci. USA102:9258.
5. Li, Y., Li, H., Ni, D. and Weigert, M. 2002. Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern. J. Exp. Med. 196:1543.
6. Yu, P., Constien, R., Dear, N. et al. 2005. Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry. Immunity 22:451.
7. Hikida, M. and Kurosaki, T. 2005. Regulation of phospholipase C-gamma2 networks in B lymphocytes. Adv. Immunol. 88:73.
8. Beutler, B., Hoebe, K., Du, X. and Ulevitch, R. J. 2003. How we detect microbes and respond to them: The Toll-like receptors and their transducers. J. Leukoc. Biol. 74:479.
9. Krieg, A. M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709.
10. Wagner, H. 2004. The immunobiology of the TLR9 subfamily. Trends Immunol. 25:381.
11. Hemmi, H., Takeuchi, O., Kawai T. et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740.
12. Suzuki, K., Mori, A., Ishii, K. J. et al. 1999. Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc. Natl Acad. Sci. USA 96:2285.
13. Yasuda, K., Yu, P., Kirschning, C. J. et al. 2005. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J. Immunol. 174: 6129.
14. Hanayama, R., Tanaka, M., Miyasaka, K. et al. 2004. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304:1147.
15. Okabe, Y., Kawane, K., Akira, S., Taniguchi, T. and Nagata, S. 2005. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202:1333.
16. Boule, M. W., Broughton, C., Mackay, F., Akira, S., Marshak-Rothstein, A. and Rifkin I. R. 2004. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199:1631.
17. Wang, Y. and Krieg, A. M. 2003. Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation. Int. Immunol. 15:223.
18. Wang, Y. and Krieg, A. M. 2004. Induction of autoantibody production but not autoimmune disease in HEL transgenic mice vaccinated with HEL in combination with CpG or control oligodeoxynucleotides. Vaccine 22:2641.
19. Rifkin, I. R., Leadbetter, E. A., Busconi, L., Viglianti, G. and Marshak-Rothstein, A. 2005. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol. Rev. 204:27.
20. Wellmann, U., Werner, A. and Winkler, T. H. 2001. Altered selection processes of B lymphocytes in autoimmune NZB/W mice, despite intact central tolerance against DNA. Eur. J. Immunol. 31:2800.
21. Viau, M. and Zouali, M. 2005. B-lymphocytes, innate immunity, and autoimmunity. Clin. Immunol. 114:17.
22. Pearson, L. and Lightfoot, R. W., Jr. 1981. Correlation of DNA-anti-DNA association rates with clinical activity in systemic lupus erythematosus (SLE). J. Immunol. 126:16.
23. ter Borg, E. J., Horst, G., Hummel, E. J., Limburg, P. C. and Kallenberg, C. G. 1990. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum. 33:634.
24. Tonuttia, E., Bassetti, D., Piazza, A. et al. 2004. Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits. Autoimmunity 37:171.
25. Anders, H. J., Vielhauer, V., Eis, V. et al. 2004. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J. 18:534.
26. Vollmer, J., Janosch, A., Laucht, M., Ballas, Z. K., Schetter, C. and Krieg, A. M. 2002. Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes. Antisense Nucleic Acid Drug Dev. 12:165.
27. Merrill, J. T., Erkan, D. and Buyon, J. P. 2004. Challenges in bringing the bench to bedside in drug development for SLE. Nat. Rev. Drug Discov. 3:1036.
28. Christen, U. and von Herrath, M. G. 2004. Initiation of autoimmunity. 1Curr. Opin. Immunol. 16:759.
29. Lenert, P. 2005. Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases? Clin. Exp. Immunol. 140:1.
30. Barrat, F. J., Meeker, T., Gregorio J. et al. 2005. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202:1131.
31. Christensen, S. R., Kashgarian, M., Alexopoulou, L., Flavell, R. A., Akira, S. and Shlomchik, M. J. 2005. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202:321.
32. Wu, X. and Peng, S. L. 2005. Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum. 54:336.
33. Lau, C. M., Broughton, C., Tabor, A. S. et al. 2005. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/ Toll-like receptor 7 engagement. J. Exp. Med. 202:1171.
34. Yu, C. C., Tsui, H. W., Ngan, B. Y., Shulman, M. J., Wu, G. E. and Tsui, F. W. 1996. B and T cells are not required for the viable motheaten phenotype. J. Exp. Med. 183:371.
35. Bolland, S., Yim, Y. S., Tus, K., Wakeland, E. K. and Ravetch, J. V. 2002. Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/ -) mice. J. Exp. Med. 195:1167.
36. Sawalha, A. H., Namjou, B., Nath, S. K. et al. 2002. Genetic linkage of systemic lupus erythematosus with chromosome 11q14 (SLEH1) in African-American families stratified by a nucleolar antinuclear antibody pattern. Genes Immun. 3(Suppl. 1):S31.
37. Ishii, K. J., Coban, C., Kato, H. et al. 2006. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7:40.
38. Hur, J. W., Shin, H. D., Park, B. L., Kim, L. H., Kim, S. Y. and Bae, S. C. 2005. Association study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus. Tissue Antigens 65:266.